BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4203142)

  • 1. Synthetic trypanocides. 3. Structure-activity relationships.
    Poliakoff N; Albonico SM; Alvarez M; Gallo Pecca J; Vernengo MJ
    J Med Chem; 1973 Dec; 16(12):1411-3. PubMed ID: 4203142
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic trypanocides: growth-inhibiting properties of new 1,2,3,4-tetrahydrocarbazoles on Trypanosoma cruzi.
    Albónico SM; Assem ME; Benages IA; Montiel AA; Pizzorno MT; Docampo R; Stoppani AO
    Rev Argent Microbiol; 1987; 19(3):121-4. PubMed ID: 3332382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new chemotype with promise against Trypanosoma cruzi.
    Wang X; Cal M; Kaiser M; Buckner FS; Lepesheva GI; Sanford AG; Wallick AI; Davis PH; Vennerstrom JL
    Bioorg Med Chem Lett; 2020 Jan; 30(1):126778. PubMed ID: 31706668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of juvenile hormone analogues (JHA) on the development of Trypanosoma cruzi.
    Fichera L; Esteva M; Wimmer Z; Rodriguez JB; Gros EG
    Z Naturforsch C J Biosci; 1995; 50(7-8):578-80. PubMed ID: 7546047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
    Ceole LF; Gandhi H; Villamizar LH; Soares MJ; O'Sullivan TP
    Future Med Chem; 2018 Feb; 10(4):391-408. PubMed ID: 29380636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semisynthesis of new aphidicolin derivatives with high activity against Trypanosoma cruzi.
    Santos GB; Krogh R; Magalhaes LG; Andricopulo AD; Pupo MT; Emery FS
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1205-8. PubMed ID: 26810263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanocidal activity and acute toxicity assessment of triterpene acids.
    Ferreira Dda S; Esperandim VR; Toldo MP; Saraiva J; Cunha WR; de Albuquerque S
    Parasitol Res; 2010 Mar; 106(4):985-9. PubMed ID: 20140451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
    Bollini M; Casal JJ; Alvarez DE; Boiani L; González M; Cerecetto H; Bruno AM
    Bioorg Med Chem; 2009 Feb; 17(4):1437-44. PubMed ID: 19168363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research for new antichagasic drugs.
    Mester B; Claramunt RM; Elguero J; Atienza J; Gómez Barrio A; Escario JA
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):1990-3. PubMed ID: 1797419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-Trypanosoma cruzi activity of new 3-phenylthio-nor-β-lapachone derivatives.
    Cardoso MFDC; Salomão K; Bombaça AC; da Rocha DR; da Silva FC; Cavaleiro JAS; de Castro SL; Ferreira VF
    Bioorg Med Chem; 2015 Aug; 23(15):4763-4768. PubMed ID: 26118339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoquinoline-based analogs of the cancer drug clinical candidate tipifarnib as anti-Trypanosoma cruzi agents.
    Chennamaneni NK; Arif J; Buckner FS; Gelb MH
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6582-4. PubMed ID: 19875282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic trypanocides. 2. Substituted 5,6-dihydro(c)benzocarbazoles.
    Gallo Pecca J; Albonico SM
    J Med Chem; 1971 May; 14(5):448-9. PubMed ID: 4940628
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents.
    Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study on the therapeutic action of Ro 7-1051 on infections caused by different strains of Trypanosoma cruzi].
    Andrade SG; Figueira RM
    Rev Inst Med Trop Sao Paulo; 1977; 19(5):335-41. PubMed ID: 416483
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazoles from nitroallylic acetates and α-bromonitroalkenes with amidines: synthesis and trypanocidal activity studies.
    Gopi E; Kumar T; Menna-Barreto RF; Valença WO; da Silva Júnior EN; Namboothiri IN
    Org Biomol Chem; 2015 Oct; 13(38):9862-71. PubMed ID: 26288376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chagas Disease: A Solvable Problem, Ignored.
    Tarleton RL
    Trends Mol Med; 2016 Oct; 22(10):835-838. PubMed ID: 27523778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
    Keenan M; Abbott MJ; Alexander PW; Armstrong T; Best WM; Berven B; Botero A; Chaplin JH; Charman SA; Chatelain E; von Geldern TW; Kerfoot M; Khong A; Nguyen T; McManus JD; Morizzi J; Ryan E; Scandale I; Thompson RA; Wang SZ; White KL
    J Med Chem; 2012 May; 55(9):4189-204. PubMed ID: 22536986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can a killer be arrested?
    Kierszenbaum F
    Nat Med; 1996 Oct; 2(10):1071-2. PubMed ID: 8837597
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
    Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H
    Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.